NFKB1 and gastric cancer: High-throughput antioxidants screening showed that several drugs, including Engeletin, which usually deactivate NF-κB signaling pathway [33], could significantly promote the proliferation in GC cells with restored CDO1, suggesting that NF-κB signaling as an antioxidant defense is probably activated in response to CDO1 re-expression.